Literature DB >> 29868707

Detection of BRAF V600E Mutations With Next-Generation Sequencing in Infarcted Thyroid Carcinomas After Fine-Needle Aspiration.

Erik Kouba1, Andrew Ford2, Charmaine G Brown2, Chen Yeh2, Gene P Siegal1, Upender Manne1, Isam-Eldin Eltoum1.   

Abstract

OBJECTIVES: Fine-needle aspiration (FNA) of thyroid lesions may result in infarction and diagnostic difficulties on subsequent thyroidectomy specimens. Next-generation sequencing (NGS) methods for detection of hallmark driver BRAF V600E mutations may help characterize such tumors in which histologic alterations preclude definitive tissue diagnosis.
METHODS: Thyroidectomy specimens with both malignant FNA diagnoses and resultant infarction were identified from our institutional database. NGS methods were used to detect BRAF V600E mutations in the infarcted thyroid carcinomas.
RESULTS: Nine thyroid carcinomas with infarction were characterized as BRAF-like papillary thyroid carcinoma based on molecular driver categorization and histologic diagnosis. BRAF V600E mutations were detected in the infarcted tissue in four (67%) of six lesions.
CONCLUSIONS: We demonstrate detection of hallmark BRAF V600E mutations by NGS within infarcted tissue of thyroid carcinomas after FNA. This suggests a potential ancillary method of characterizing infarcted thyroid carcinomas whose altered histology may be nondiagnostic.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29868707      PMCID: PMC8482970          DOI: 10.1093/ajcp/aqy045

Source DB:  PubMed          Journal:  Am J Clin Pathol        ISSN: 0002-9173            Impact factor:   2.493


  52 in total

Review 1.  Histological alterations following thyroid fine needle biopsy: a systematic review.

Authors:  Stergios A Polyzos; Kalliopi Patsiaoura; Konstantia Zachou
Journal:  Diagn Cytopathol       Date:  2009-06       Impact factor: 1.582

2.  Infarcted papillary thyroid cancer after fine needle aspiration biopsy.

Authors:  Eric J Epstein; Jing Chao; Christian Keller; Antonio Cajigas
Journal:  Endocrine       Date:  2011-10       Impact factor: 3.633

Review 3.  Molecular diagnostics for thyroid nodules: the current state of affairs.

Authors:  Sann Yu Mon; Steven P Hodak
Journal:  Endocrinol Metab Clin North Am       Date:  2014-06       Impact factor: 4.741

Review 4.  BRAF mutation in papillary thyroid cancer and its value in tailoring initial treatment: a systematic review and meta-analysis.

Authors:  Ralph P Tufano; Gilberto V Teixeira; Justin Bishop; Kathryn A Carson; Mingzhao Xing
Journal:  Medicine (Baltimore)       Date:  2012-09       Impact factor: 1.889

Review 5.  BRAF mutation in thyroid cancer.

Authors:  M Xing
Journal:  Endocr Relat Cancer       Date:  2005-06       Impact factor: 5.678

6.  Genetic alterations and their relationship in the phosphatidylinositol 3-kinase/Akt pathway in thyroid cancer.

Authors:  Peng Hou; Dingxie Liu; Yuan Shan; Shuiying Hu; Kimberley Studeman; Stephen Condouris; Yangang Wang; Ariel Trink; Adel K El-Naggar; Giovanni Tallini; Vasily Vasko; Mingzhao Xing
Journal:  Clin Cancer Res       Date:  2007-02-15       Impact factor: 12.531

Review 7.  Biologic and Clinical Perspectives on Thyroid Cancer.

Authors:  James A Fagin; Samuel A Wells
Journal:  N Engl J Med       Date:  2016-09-15       Impact factor: 91.245

8.  Yield of repeat fine-needle aspiration biopsy and rate of malignancy in patients with atypia or follicular lesion of undetermined significance: the impact of the Bethesda System for Reporting Thyroid Cytopathology.

Authors:  Joy C Chen; S Carter Pace; Boris A Chen; Amer Khiyami; Christopher R McHenry
Journal:  Surgery       Date:  2012-10-03       Impact factor: 3.982

9.  Mutational profile of advanced primary and metastatic radioactive iodine-refractory thyroid cancers reveals distinct pathogenetic roles for BRAF, PIK3CA, and AKT1.

Authors:  Julio C Ricarte-Filho; Mabel Ryder; Dhananjay A Chitale; Michael Rivera; Adriana Heguy; Marc Ladanyi; Manickam Janakiraman; David Solit; Jeffrey A Knauf; R Michael Tuttle; Ronald A Ghossein; James A Fagin
Journal:  Cancer Res       Date:  2009-06-01       Impact factor: 12.701

Review 10.  The utility of BRAF testing in the management of papillary thyroid cancer.

Authors:  Adrienne L Melck; Linwah Yip; Sally E Carty
Journal:  Oncologist       Date:  2010-12-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.